Sign in

CIK 0001840706

  • Accelerated filer
  • Emerging growth company

SOPHiA GENETICS SA

Sign in to watch
Ticker
SOPH
Exchange
Nasdaq
Industry
Services-Computer Processing & Data Preparation
FY end
Dec 31
Incorporated
Switzerland
Entity type
Other
Phone
+41 216941060
Business address
LA PIECE, CH-1180, ROLLE, Switzerland, 00000
  1. 4 Grant or award Director acquired 19,724 shares (grant or award)
  2. 4 Grant or award Director acquired 19,724 shares (grant or award)
  3. 4 Grant or award Director acquired 19,724 shares (grant or award)
  4. 4 Grant or award Director acquired 19,724 shares (grant or award)
  5. 4 Grant or award Director acquired 19,724 shares (grant or award)
  6. 4 Planned sale Chief Scientific Officer sold 4,000 shares at $5.01 ($20,056)
  7. 4 Planned sale Chief Medical Officer sold 5,000 shares at $4.95 ($24,752)
  8. 4 Planned sale Chief Executive Officer sold 8,500 shares at $5.24 ($44,501)
  9. 4 Open-market buy Chief Financial Officer bought 20,000 shares at $4.95 ($99,000)
  10. 4 Planned sale Chief Medical Officer sold 5,000 shares at $4.95 ($24,774)
  11. 4 Planned sale President sold 761 shares at $4.60 ($3,501)
  12. 4 Planned sale Chief Scientific Officer sold 608 shares at $4.60 ($2,798)
  13. 4 Planned sale Chief Executive Officer sold 4,486 shares at $4.60 ($20,658)
  14. 4 Planned sale Chief Medical Officer sold 608 shares at $4.61 ($2,800)
  15. 4 Planned sale Chief Legal Officer sold 684 shares at $4.60 ($3,149)
  16. 4 Planned sale Chief People Officer sold 380 shares at $4.60 ($1,747)
  17. 4 Open-market sale Chief Sales Officer sold 33 shares at $4.54 ($150)
  18. 4 Planned sale Chief Scientific Officer sold 4,000 shares at $4.54 ($18,168)
  19. 4 Planned sale Director sold 7,508 shares at $4.67 ($35,037)
  20. 4 Planned sale Chief Medical Officer sold 5,000 shares at $4.67 ($23,345)

Page 4 of 8 · 156 filings